ReviewEcancermedicalscience2026

Access to cancer medicines in Kenya: a scoping review of costs, financial toxicity, quality of life and policy impacts.

James Onyuro Oketch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.